CB2 has been shown to play a regulatory role in neuroinflammatory and neurodegenerative diseases such as Alzheimer’s disease (AD), Huntington’s disease (HD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). Here, CNR2 is linked to Alzheimer disease.